Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2431 AL 2445

Personalized chronic adaptive deep brain stimulation outperforms conventional stimulation in Parkinson's disease

Oehrn CR, Cernera S, Hammer LH, Shcherbakova M, Yao J, Hahn A, Wang S, Ostrem JL, Little S, Starr PA.

medRxiv [Preprint]. 2023 Aug 8:2023.08.03.23293450. doi: 10.1101/2023.08.03.23293450.

Non-Pharmacological Treatments in Lewy Body Disease: A Systematic Review

Guidi L, Evangelisti S, Siniscalco A, Lodi R, Tonon C, Mitolo M.

Dement Geriatr Cogn Disord. 2023;52(1):16-31. doi: 10.1159/000529256. Epub 2023 Mar 28.

Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson's Disease

Brillman S, Khemani P, Isaacson SH, Pahwa R, Deshpande R, Zraick V, Rajagopal A, Khosla D, Rosenbluth KH.

Tremor Other Hyperkinet Mov (N Y). 2023 Aug 23;13:25. doi: 10.5334/tohm.762. eCollection 2023.

Pyridazine Derivatives as NLRP3 Inhibitors for Treating Asthma, COPD, Parkinson's Disease, and Alzheimer's Disease

Sabnis RW.

ACS Med Chem Lett. 2023 Aug 1;14(8):1047-1048. doi: 10.1021/acsmedchemlett.3c00311. eCollection 2023 Aug 10.

Impaired cognitive and motor function are coincident with L-DOPA-induced dyskinesia in a model of Parkinson's disease

Lelos MJ, Murphy EM, Lindgren HS, Dunnett SB, Lane EL.

Sci Rep. 2023 Oct 17;13(1):17697. doi: 10.1038/s41598-023-44869-y.

Transcriptomic changes in oligodendrocytes and precursor cells predicts clinical outcomes of Parkinson's disease

Dehestani M, Kozareva V, Blauwendraat C, Fraenkel E, Gasser T, Bansal V.

bioRxiv [Preprint]. 2023 Dec 6:2023.05.11.540329. doi: 10.1101/2023.05.11.540329.

The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson's disease

Gabbert C, Blöbaum L, Lüth T, König IR, Caliebe A, Koch S, Björn-Hergen L, Klein C, Trinh J.

medRxiv [Preprint]. 2023 Aug 25:2023.08.25.23294466. doi: 10.1101/2023.08.25.23294466.

Genome-wide QTL mapping across three tissues highlights several Alzheimer's and Parkinson's disease loci potentially acting via DNA methylation

Ohlei O, Sommerer Y, Dobricic V, Homann J, Deecke L, Schilling M, Bartrés-Faz D, Cattaneo G, Düzel S, Fjell AM, Lindenberger U, Pascual-Leone Á, Sedghpour Sabet S, Solé-Padullés C, Tormos JM, Vetter VM, Walhovd KB, Wesse T, Wittig M, Franke A, Demuth I, Lill CM, Bertram L.

medRxiv [Preprint]. 2023 Dec 24:2023.12.22.23300365. doi: 10.1101/2023.12.22.23300365.

Phosphoglycerate kinase is a central leverage point in Parkinson's Disease driven neuronal metabolic deficits

Kokotos AC, Antoniazzi AM, Unda SR, Ko MS, Park D, Eliezer D, Kaplitt MG, Camilli P, Ryan TA.

bioRxiv [Preprint]. 2023 Oct 10:2023.10.10.561760. doi: 10.1101/2023.10.10.561760.

Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo

Straumann N, Combes BF, Dean Ben XL, Sternke-Hoffmann R, Gerez JA, Dias I, Chen Z, Watts B, Rostami I, Shi K, Rominger A, Baumann CR, Luo J, Noain D, Nitsch RM, Okamura N, Razansky D, Ni R.

bioRxiv [Preprint]. 2023 Jun 30:2023.06.28.546962. doi: 10.1101/2023.06.28.546962.

What neurological diseases tell us about procedural perceptual-motor learning? A systematic review of the literature

Martin E, Scotté-Barranoff C, Tallet J.

Neurol Sci. 2023 Aug;44(8):2645-2665. doi: 10.1007/s10072-023-06724-w. Epub 2023 Mar 28.

Novel C-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson's Disease

Sabnis RW, Sabnis AR.

ACS Med Chem Lett. 2023 May 16;14(6):698-699. doi: 10.1021/acsmedchemlett.3c00179. eCollection 2023 Jun 8.

Sex differences in alpha-synucleinopathies: a systematic review

Raheel K, Deegan G, Di Giulio I, Cash D, Ilic K, Gnoni V, Chaudhuri KR, Drakatos P, Moran R, Rosenzweig I.

Front Neurol. 2023 Jul 20;14:1204104. doi: 10.3389/fneur.2023.1204104. eCollection 2023.

Neuroinflammatory disorders of the brain and inner ear: a systematic review of auditory function in patients with migraine, multiple sclerosis, and neurodegeneration to support the idea of an innovative 'window of discovery'

Di Stadio A, De Luca P, Koohi N, Kaski D, Ralli M, Giesemann A, Hartung HP, Altieri M, Messineo D, Warnecke A, Frohman T, Frohman EM.

Front Neurol. 2023 Aug 10;14:1204132. doi: 10.3389/fneur.2023.1204132. eCollection 2023.

Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19

Mancini M, Natoli S, Gardoni F, Di Luca M, Pisani A.

Int J Mol Sci. 2023 Mar 15;24(6):5618. doi: 10.3390/ijms24065618.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias